SLC31A1 and breast cancer: SLC31A1 emerged as a prospective cuproptosis-related gene in breast cancer, displaying significant upregulation. It exhibited promising potential in forecasting prognosis, aiding in diagnosis, and predicting drug sensitivity in breast cancer cases.